ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.00%
Brent Oil
76.495
0.00%
Bitcoin
98,247.83
0.04%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Monbat Ad (0NH6) Cotización

Monbat Ad

Monbat Ad (0NH6)

LSE
8.75
0.00
(0.00%)
Cerrado 05 Enero 10:30AM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
8.75
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
8.75 Rango de 52 semanas 8.75
Capitalización de Mercado [m]
341.25M
Precio Anterior
8.75
Precio de Apertura
-
Hora
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
0.00
Acciones en circulación
39,000,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
54.08
Beneficio por acción (BPA)
0.16
turnover
383.56M
Beneficio neto
6.31M

Acerca de Monbat Ad

Sector
Primary Batteries, Dry & Wet
Industria
Primary Batteries, Dry & Wet
Sitio web
www.monbat.com
Sede
Sofia, Bgr
Fundado
-
Monbat Ad is listed in the Primary Batteries, Dry & Wet sector of the London Stock Exchange with ticker 0NH6. The last closing price for Monbat Ad was BGN8.75. Over the last year, Monbat Ad shares have traded in a share price range of BGN 8.75 to BGN 8.75.

Monbat Ad currently has 39,000,000 shares in issue. The market capitalisation of Monbat Ad is BGN341.25 million. Monbat Ad has a price to earnings ratio (PE ratio) of 54.08.

0NH6 Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1008.758.758.7500DE
4008.758.758.7500DE
12008.758.758.7500DE
26008.758.758.7500DE
52008.758.758.7500DE
156008.758.758.7500DE
260008.758.758.7500DE

0NH6 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Monbat Ad?
El precio actual de las acciones de Monbat Ad es BGN 8.75
¿Cuántas acciones de Monbat Ad están en circulación?
Monbat Ad tiene 39,000,000 acciones en circulación
¿Cuál es la capitalización de mercado de Monbat Ad?
La capitalización de mercado de Monbat Ad es BGN 341.25M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Monbat Ad?
Monbat Ad ha negociado en un rango de BGN 8.75 a BGN 8.75 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Monbat Ad?
El ratio precio/beneficio de Monbat Ad es 54.08
¿Cuál es el ratio de efectivo a ventas de Monbat Ad?
El ratio de efectivo a ventas de Monbat Ad es 0.89
¿Cuál es la moneda de reporte de Monbat Ad?
Monbat Ad presenta sus resultados financieros en BGN
¿Cuál es el último ingresos anual de Monbat Ad?
El último ingresos anual de Monbat Ad es BGN 383.56M
¿Cuál es el último beneficio anual de Monbat Ad?
El último beneficio anual de Monbat Ad es BGN 6.31M
¿Cuál es la dirección registrada de Monbat Ad?
La dirección registrada de Monbat Ad es 32 A CHERNI VRAH BLVD., FL. 4, SOFIA, 1407
¿Cuál es la dirección del sitio web de Monbat Ad?
La dirección del sitio web de Monbat Ad es www.monbat.com
¿En qué sector industrial opera Monbat Ad?
Monbat Ad opera en el sector PRIMARY BATTERIES, DRY & WET

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discusión

Ver feed completo
DonVance DonVance 4 minutos hace
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 5 minutos hace
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 6 minutos hace
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 7 minutos hace
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 9 minutos hace
The Russes hit the jackpot?
BDEZ BDEZ 10 minutos hace
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 10 minutos hace
Not good, thanks for sharing.
sand sand 17 minutos hace
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 18 minutos hace
Moving hard soon 
EFSH
mining101 mining101 19 minutos hace
Superb
MEGL
benz280c benz280c 26 minutos hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 33 minutos hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 34 minutos hace
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 37 minutos hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 42 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 43 minutos hace
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 48 minutos hace
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 50 minutos hace
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 51 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 53 minutos hace
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 56 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 59 minutos hace
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 59 minutos hace
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO

Su Consulta Reciente

LSE
0NH6
Monbat Ad
TG
A0TMMY
Dev Bk Jap4
TG
A181QL
Schweiz Eidgenossenschaft
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados